RENBP and neoplasm: Another common mode of action of anti-tumour mAbs is complement-dependent cytotoxicity (CDC), in which direct interaction of surface Ag-bound Abs with complement C1q triggers cell death through the complement cascade (Idusogie et al, 2001; Weiner, 2010).